✦ LIBER ✦

Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin

✍ Scribed by Georgios Chamilos; Aristotle Bamias; Eleni Efstathiou; Pagona M. Zorzou; Efstathios Kastritis; Evagelos Kostis; Christos Papadimitriou; Meletios A. Dimopoulos

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 83 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21089

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outpatient treatment of febrile episodes

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

✍ Edward B Rubenstein; Kenneth Rolston; Carmen Escalante; Ellen Manzullo; Pamela H 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

Outpatient treatment of fever and neutro

Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients

✍ Craig A. Mullen; Demetrios Petropoulos; W. Mark Roberts; Michael Rytting; Theodo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## BACKGROUND. Fever and neutropenia (F&N) is a common complication of cancer chemotherapy. It is conveniently managed by hospitalization and empiric administration of parenteral antibiotics. This study attempted to determine whether pediatric cancer patients with F&N identified as low risk for mo

Assessment and treatment of low-risk feb

Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer

✍ Zubizarreta, Pedro ;Paganini, Hugo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB

How should imipenem-cilastatin be Used i

How should imipenem-cilastatin be Used in the treatment of fever and infection in neutropenic cancer patients?

✍ Issam I. Raad; Dima Abi-Said; Kenneth V. Rolston; Cynthia L. Karl; Gerald P. Bod 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Background: Imipenem-cilastatin (referred to hereafter as imipenem) is administered at different doses as monotherapy or with other agents. limited comparisons of the alternatives exist. the authors compared the efficacy and safety of several imipenem-containing regimens (icrs) to determine the

Once daily, oral, outpatient quinolone m

Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia : A pilot study of 40 patients based on validated risk-prediction rules

✍ Kenneth V. I. Rolston; Ellen F. Manzullo; Linda S. Elting; Susan E. Frisbee-Hume 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Oral ciprofloxacin vs. intravenous ceftr

Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial

✍ Petrilli, Antonio S�rgio; Dantas, Lenice Silva; Campos, M�nica Cypriano; Tanaka, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

Background. Infections are one of the major complications in children undergoing chemotherapy. Monotherapy with either ciprofloxacin or ceftriaxone is safe and efficient in low-risk patients (solid tumors and stage I/II lymphomas). The same drugs may be used in an outpatient setting, decreasing cost